Covered recipient · General Payments record
OMARAN ADNAN ABDEEN
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$2,724.80
- Reported across 136 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $480.21 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $343.95 | 21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.96 | 2 |
| Novo Nordisk AS | $44.95 | 2 |
| Fresenius USA Marketing, Inc. | $25.00 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $26.81 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406374 | CMS |
| Amgen Inc. | $8.43 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406378 | CMS |
| Amgen Inc. | $16.67 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406382 | CMS |
| Amgen Inc. | $23.88 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406386 | CMS |
| Amgen Inc. | $8.62 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406390 | CMS |
| Amgen Inc. | $12.78 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406394 | CMS |
| Amgen Inc. | $21.03 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406457 | CMS |
| Amgen Inc. | $10.73 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406398 | CMS |
| Amgen Inc. | $25.16 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406402 | CMS |
| Amgen Inc. | $10.80 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406407 | CMS |
| Amgen Inc. | $17.76 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406411 | CMS |
| Amgen Inc. | $13.74 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406415 | CMS |
| Amgen Inc. | $6.23 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406419 | CMS |
| Amgen Inc. | $30.31 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406423 | CMS |
| Amgen Inc. | $19.90 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406428 | CMS |
| Amgen Inc. | $21.96 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406432 | CMS |
| Amgen Inc. | $17.31 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406436 | CMS |
| Amgen Inc. | $8.30 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406441 | CMS |
| Amgen Inc. | $7.78 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406445 | CMS |
| Amgen Inc. | $15.57 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406448 | CMS |
| Amgen Inc. | $20.18 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115406453 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.35 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086255074 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.83 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118120589 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.13 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118120587 | CMS |
| Fresenius USA Marketing, Inc. | $25.00 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154192397 | CMS |
| Novo Nordisk Inc | $22.70 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097306947 | CMS |
| Novo Nordisk Inc | $22.25 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097253686 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.